CHARISE GLEASON: Open Payments
NPI 1871605840 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,144 in 6 payments from 3 companies in 2025. Trend: 2023 $3,155 · 2024 $2,643 · 2025 $2,144
Grant: $1,914Food & beverage: $230
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $1,914 |
| Celgene Corporation | 2 | $205 |
| Janssen Biotech, Inc. | 1 | $24 |
Products named: ABECMA.
Industry payments across GA — which companies pay providers there.
